for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Cue Biopharma Provides Update On Ongoing Phase 1 Trial Evaluating CUE-101 In Metastatic Head And Neck Cancer

June 15 (Reuters) - Cue Biopharma Inc:

* CUE BIOPHARMA PROVIDES UPDATE ON ONGOING PHASE 1 TRIAL EVALUATING CUE-101 IN RECURRENT/METASTATIC HEAD AND NECK CANCER

* CUE BIOPHARMA INC - PATIENT ENROLLMENT AND DATA GENERATION REMAIN ON SCHEDULE FOR CUE-101 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up